The largest database of trusted experimental protocols

3730 platform

Manufactured by Thermo Fisher Scientific

The 3730 platform is a capillary electrophoresis system designed for genetic analysis. It features a 96-well sample capacity and supports a range of applications, including DNA sequencing, fragment analysis, and genotyping. The system provides high-quality data and efficient sample processing.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using 3730 platform

1

16S rDNA Sequencing and Phylogenetic Analysis of Janibacter YFY001

Check if the same lab product or an alternative is used in the 5 most similar protocols
Janibacter YFY001 was grown in nutrient broth (Co. Oxford) for 96 hours at 37 degrees Celsius before genomic DNA was extracted using a QIAamp DNA Mini Kit. Subsequently, 16S rDNA amplification was carried out using the universal 16S rDNA primers 27f (AGAGTTTGATCMTGGCTCAG) and 1492r (GGTTACCTTGTTACGACTT).15 (link) The amplification product was sequenced using the Applied Biosystems 3730 platform. After sequencing, contigs were assembled and blasted using the NCBI website (http://www.ncbi.nlm.nih.gov/) using the 16S ribosome RNA database.
To elucidate the phylogeny between our isolate and remaining strains, 16S rDNA sequences were collected and MEGA6 was used for the phylogenetic analysis.
+ Open protocol
+ Expand
2

Variant Discovery and Prioritization Pipeline

Check if the same lab product or an alternative is used in the 5 most similar protocols
After demultiplexing and FASTQ generation, the paired-end reads were trimmed using TrimGalore v0.4.4. The paired-end reads were then aligned to hg19 human reference genome with BWA v0.7.15-r1140 (11 (link)). We applied the GATK v3.7 pipeline (12 (link)) for indel realignment, duplicate removal, and performed SNP and INDEL discovery as well as share genotype across both the proband and her father’s samples simultaneously according to GATK Best Practices recommendations (14 (link), 15 (link)). Variants were annotated and filtered with Agilent Technologies Bench Lab NGS v5.0.2. To select putative pathogenic variants, filters were applied as follows (Supplementary Fig. 1, see section on supplementary materials given at the end of this article): (i) variants common to proband and her father were filtered out; (ii) low quality reads were filtered out; (iii) only heterozygous variants were retained; (iv) variants predicted as pathogenic (Supplementary Fig. 1) were retained; (v) variants in exonic regions or near splicing sites were retained; (vi) variants with a frequency ≥0.01 in the general population (using Exac database, release 0.3, 1000 Genomes Phase1 release v3.20101123, ESP6500SI-V2, 1000 Genomes Phase 3 release v5.20130502) were filtered out. Relevant nucleotide variants were validated by Sanger sequencing on Applied Biosystems 3730 platform.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!